Research / BWA / Fundamental state Inspectable configuration
State dimensions Filing 0000908255-18-000017 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
21.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.04% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
8.03% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
7.82% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
21.64% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
10.99% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.16% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.54% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 18 states Self-history eligible
Dec 31, 2016 0/8 normalized Level 3 Dec 31, 2017 0/9 normalized Level 3 Dec 31, 2017 0/9 normalized Amended as filed Sep 30, 2018 0/8 normalized Level 3 Dec 31, 2018 0/9 normalized Level 3 Mar 31, 2019 0/8 normalized Level 3 Jun 30, 2019 0/8 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 8/9 normalized Level 3 Jun 30, 2020 8/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 22.74%
Current 21.63%
Delta -1.11% Capex Intensity Increased
Previous 5.52%
Current 5.71%
Delta 0.20% Cash Generation Increased
Previous 11.42%
Current 12.04%
Delta 0.63% Inventory Pressure Increased
Previous 7.07%
Current 7.82%
Delta 0.75% Margin Increased
Previous 21.31%
Current 21.64%
Delta 0.32% Profitability Increased
Previous 2.49%
Current 10.99%
Delta 8.50% R And D Intensity Increased
Previous 3.78%
Current 4.16%
Delta 0.38% Sbc Intensity Increased
Previous 0.48%
Current 0.54%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.